1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Allergic Rhinitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachert, C; González-Núñez, V; Mullol, J | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Allergic Rhinitis
| Article | Year |
|---|---|
Rupatadine: global safety evaluation in allergic rhinitis and urticaria.
Topics: Animals; Anti-Allergic Agents; Blood-Brain Barrier; Cyproheptadine; Histamine H1 Antagonists; Humans; Platelet Activating Factor; Rhinitis, Allergic; Urticaria | 2016 |